Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events

被引：0
|
作者：
Helen Y Chu
Rupali Jain
Hu Xie
Paul Pottinger
David N Fredricks
机构：
[1] University of Washington,Division of Allergy & Infectious Diseases, Department of Medicine
[2] University of Washington Medical Center,Department of Pharmacy
[3] Fred Hutchinson Cancer Research Center,Vaccine and Infectious Diseases Division
来源：
BMC Infectious Diseases | / 13卷
关键词：
Voriconazole; Therapeutic drug monitoring; Antifungals; Clinical efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data
    Matsumoto, Kazuaki
    Abematsu, Kazuko
    Shigemi, Akari
    Kanazawa, Naoko
    Watanabe, Erika
    Yokoyama, Yuta
    Ikawa, Kazuro
    Morikawa, Norifumi
    Takeda, Yasuo
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (03) : 198 - 202
  • [32] Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring
    Eiden, Celine
    Cociglio, Marylene
    Hillaire-Buys, Dominique
    Eymard-Duvernay, Sabrina
    Ceballos, Patrice
    Fegueux, Nathalie
    Peyriere, Helene
    XENOBIOTICA, 2010, 40 (10) : 701 - 706
  • [33] Clinical benefits of therapeutic drug monitoring of vancomycin therapy in patients with postoperative intracerebral hemorrhage: a retrospective cohort study
    Liu, Huanhuan
    Yang, Hongxin
    Guo, Xiaobin
    Bai, Yingchun
    SiRi, Guleng
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (03) : 240 - 246
  • [34] Level of Evidence for Therapeutic Drug Monitoring of Voriconazole
    Hulin, Anne
    Dailly, Eric
    Le Guellec, Chantal
    THERAPIE, 2011, 66 (02): : 109 - 114
  • [35] Voriconazole Therapeutic Drug Monitoring: How to Adjust the Dose in Pediatrics?
    Faghihi, Toktam
    Tiihonen, Miia
    IRANIAN JOURNAL OF PEDIATRICS, 2021, 31 (02)
  • [36] Voriconazole therapeutic drug monitoring: focus on safety
    Pasqualotto, Alessandro C.
    Xavier, Melissa O.
    Andreolla, Huander F.
    Linden, Rafael
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 125 - 137
  • [37] Therapeutic drug monitoring and safety of voriconazole in patients with liver dysfunction
    Hu, Lin
    Su, Yuan
    Tang, Xi
    Li, Yanfei
    Feng, Jinhui
    He, Gefei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (11)
  • [38] Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study
    Wang, Taotao
    Miao, Liyan
    Shao, Hua
    Wei, Xiaohua
    Yan, Miao
    Zuo, Xiaocong
    Zhang, Jun
    Hai, Xin
    Fan, Guangjun
    Wang, Wei
    Hu, Linlin
    Zhou, Jian
    Zhao, Yichang
    Xie, Yueliang
    Wang, Jingjing
    Guo, Sixun
    Jin, Liu
    Li, Hao
    Liu, Hui
    Wang, Quanfang
    Chen, Jiaojiao
    Li, Sihan
    Dong, Yalin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (5-6)
  • [39] Therapeutic drug monitoring of clozapine and relapse - a retrospective study of routine clinical data
    Ulrich, S
    Baumann, B
    Wolf, R
    Lehmann, D
    Peters, B
    Bogerts, B
    Meyer, FP
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2003, 41 (01) : 3 - 13
  • [40] Effect of Therapeutic Drug Monitoring and Cytochrome P450 2C19 Genotyping on Clinical Outcomes of Voriconazole: A Systematic Review
    Lee, Joseph
    Ng, Patrick
    Hamandi, Bassem
    Husain, Shahid
    Lefebvre, Melissa J.
    Battistella, Marisa
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (04) : 509 - 529
12345